Harvard Apparatus Regenerative Technology, Inc. Operating Income

Quick Answer

Harvard Apparatus Regenerative Technology, Inc. reported Operating Income of -$6.92 million for fiscal year 2025.

Harvard Apparatus Regenerative Technology, Inc. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$6.92M +10.5%
2024 -$7.73M +14.1%
2023 -$8.99M -46.1%
2022 -$6.15M +28.8%
2021 -$8.64M -62.2%
2020 -$5.33M +40.0%
2019 -$8.87M -13.1%
2018 -$7.84M +31.6%
2017 -$11.47M +5.4%
2016 -$12.13M -3.6%
2015 -$11.70M -5.8%
2014 -$11.06M -25.4%
2013 -$8.82M -31.3%
2012 -$6.71M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$1.71M +7.8% +6.5%
June 30, 2025 -$1.83M +26.1% -9.8%
March 31, 2025 -$1.67M +17.4% +10.2%
September 30, 2024 -$1.86M -14.5% +25.1%
June 30, 2024 -$2.48M +6.4% -22.8%
March 31, 2024 -$2.02M +30.0% -24.4%
September 30, 2023 -$1.62M -50.4% +38.7%
June 30, 2023 -$2.65M -92.8% +8.2%
  • Harvard Apparatus Regenerative Technology, Inc. showed an increase of +10.5% in Operating Income compared to the prior fiscal year.
  • Over the 2012–2025 period, Harvard Apparatus Regenerative Technology, Inc.’s operating income has declined by 3.0% (from -$6.71 million to -$6.92 million).
  • The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment